All cancer types, Oesophageal cancer
Results
Phase 1
This study looked at Berzosertib (M6620) with:
radiotherapy for oesophageal cancer
chemotherapy for other solid tumours
A solid tumour is any cancer apart from blood cancers such as leukaemia, lymphoma or myeloma.
The study was supported by Cancer Research UK. It was open for people to join between 2018 and 2021. The team analysed the results in 2022.
Recruitment start: 4 December 2018
Recruitment end: 31 December 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Maria Hawkins
Cancer Research UK
Merck KGaA
University of Oxford
Oncology Clinical Trials Office (OCTO), University of Oxford
CRUK/MRC Oxford Institute for Radiation Oncology
Experimental Cancer Medicine Centre (ECMC)
This is Cancer Research UK trial number CRUKD/15/011.
Last reviewed: 22 May 2023
CRUK internal database number: 14312
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
